U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552636) titled 'Disease Activity Monitoring in Patients With Giant Cell Arteritis Study' on April 20.
Brief Summary: Giant Cell Arteritis (GCA) is a vasculitis of medium- and large-sized arteries in older adults that may lead to serious vascular complications, including permanent vision loss and aortic aneurysm formation. Glucocorticoids are effective, but relapse during tapering is common and poses a major clinical challenge, potentially contributing to prolonged glucocorticoid exposure. Symptoms are often nonspecific and conventional inflammatory markers lack sufficient reliability, particularly in patients treated with drugs targeting the IL-6 ...